We are live on ! Find out more
PCH

Polar Capital Holdings Portfolio holdings

AUM $42.4B
1-Year Est. Return 181.11%
This Fund
S&P 500
This Quarter Est. Return
-0.56%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
–
AUM
$15.7B
AUM Growth
-$1.33B
Cap. Flow
-$153M
Cap. Flow %
-0.98%
Top 10 Hldgs %
39.89%
Holding
471
New
38
Increased
139
Reduced
173
Closed
54

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$70.7M
2
META icon
Meta Platforms (Facebook)
META
+$66.5M
3
BDX icon
Becton Dickinson
BDX
+$61.6M
4
GTLB icon
GitLab
GTLB
+$58.7M
5
TER icon
Teradyne
TER
+$58.7M

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$85.2M
2
STE icon
Steris
STE
+$78.2M
3
CVS icon
CVS Health
CVS
+$62.9M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$61.9M
5
FIVN icon
FIVE9
FIVN
+$58.8M

Sector Composition

Rank Sector Weight
1 Technology 30.08%
2 Industrials 22.24%
3 Healthcare 19.2%
4 Financials 15.72%
5 Communication Services 5.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TER icon
76
Teradyne
TER
$51.5B
$48.4M 0.31%
+643,544
New +$58.7M
RBLX icon
77
Roblox
RBLX
$36.6B
$47.2M 0.3%
1,317,304
-91,602
-7% -$3.79M
RYAN icon
78
Ryan Specialty Holdings
RYAN
$4.65B
$46.7M 0.3%
1,150,000
– –
FIVN icon
79
FIVE9
FIVN
$2.37B
$46M 0.29%
613,336
-605,412
-50% -$58.8M
AVTR icon
80
Avantor
AVTR
$10.3B
$44.9M 0.29%
2,292,272
+274,094
+14% +$7.34M
TENB icon
81
Tenable Holdings
TENB
$3.86B
$44.3M 0.28%
1,272,013
-202,646
-14% -$8.5M
MU icon
82
Micron Technology
MU
$1.04T
$44.1M 0.28%
880,679
-768,983
-47% -$44.6M
ABBV icon
83
AbbVie
ABBV
$454B
$44.1M 0.28%
328,510
+45,718
+16% +$6.56M
FRSH icon
84
Freshworks
FRSH
$3.3B
$43.9M 0.28%
3,383,977
+2,009,264
+146% +$28.4M
BIO icon
85
Bio-Rad Laboratories Class A
BIO
$9.87B
$43.2M 0.28%
103,654
-11,405
-10% -$5.69M
GMED icon
86
Globus Medical
GMED
$9.96B
$43.2M 0.28%
725,308
+11,960
+2% +$720K
LEGN icon
87
Legend Biotech
LEGN
$3.6B
$43M 0.27%
1,054,017
+479,930
+84% +$22.5M
TRUP icon
88
Trupanion
TRUP
$1.09B
$42.2M 0.27%
710,000
+10,000
+1% +$672K
CLDX icon
89
Celldex Therapeutics
CLDX
$3.08B
$40.7M 0.26%
1,448,934
+801,514
+124% +$24.6M
PRA
90
DELISTED
ProAssurance
PRA
$39.8M 0.25%
2,037,500
+87,500
+4% +$1.92M
ANGO icon
91
AngioDynamics
ANGO
$631M
$38.3M 0.24%
1,872,236
– –
SNY icon
92
Sanofi
SNY
$104B
$38M 0.24%
1,000,000
+275,000
+38% +$12.3M
BLU
93
DELISTED
BELLUS Health Inc.
BLU
$37.4M 0.24%
3,537,225
+37,225
+1% +$396K
LLY icon
94
Eli Lilly
LLY
$1.01T
$36.6M 0.23%
113,138
+74,144
+190% +$23.5M
YMAB
95
DELISTED
Y-mAbs Therapeutics
YMAB
$36.5M 0.23%
2,531,546
-421,125
-14% -$6.97M
LIVN icon
96
LivaNova
LIVN
$4.44B
$35.2M 0.22%
693,832
+20,128
+3% +$1.19M
MYOV
97
DELISTED
Myovant Sciences Ltd.
MYOV
$35M 0.22%
+1,947,906
New +$31.1M
ISEE
98
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$33.5M 0.21%
1,868,628
– –
ADUS icon
99
Addus HomeCare
ADUS
$2.19B
$33M 0.21%
346,297
– –
NSTG
100
DELISTED
NanoString Technologies, Inc.
NSTG
$32.9M 0.21%
2,576,357
+550,188
+27% +$7.64M
2 3
4
5 6

Similar funds

Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $41.9B AUM 18.91% 1-Year Est. Return
GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $41.5B AUM 16.76% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $40.6B AUM 38.65% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Polar Capital Holdings's Q3 2022 Portfolio in Review

As of Q3 2022, Polar Capital Holdings held 471 positions worth $15.7B, down 7.8% from $17B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Polar Capital Holdings's Q3 2022 filing shows 38 new, 139 increased, 173 reduced and 54 closed positions. Its largest new stake was DexCom: 834,956 shares worth $67.2M. The largest sale was Adobe, an estimated $85.2M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Industrials and Healthcare.

  • Polar Capital Holdings's largest Q3 2022 buy was DexCom: 834,956 shares worth $67.2M.
  • Polar Capital Holdings added most to Meta Platforms (Facebook) in Q3 2022, an estimated $66.5M increase.
  • Polar Capital Holdings's biggest Q3 2022 reduction was Neurocrine Biosciences, cutting an estimated $61.9M.
  • Polar Capital Holdings fully exited Adobe in Q3 2022, selling an estimated $85.2M.
  • Polar Capital Holdings's ten largest holdings make up 40% of its $15.7B portfolio in Q3 2022.
  • Polar Capital Holdings opened 38 new positions and closed 54 in Q3 2022.
  • Polar Capital Holdings's portfolio value fell 7.8% quarter-over-quarter to $15.7B.

Based on Polar Capital Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.